Compare HUMAW & AGNCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
Current Price
| Metric | HUMAW | AGNCM |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | 184 | 54 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | HUMAW | AGNCM |
|---|---|---|
| Price | $0.05 | $25.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 15.8K | 10.4K |
| Earning Date | 03-21-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 8.99% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.57 |
| Revenue Next Year | N/A | $63.17 |
| P/E Ratio | ★ N/A | $17.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.04 | $23.63 |
| 52 Week High | $0.60 | $25.34 |
| Indicator | HUMAW | AGNCM |
|---|---|---|
| Relative Strength Index (RSI) | 43.56 | 60.96 |
| Support Level | N/A | $24.79 |
| Resistance Level | $0.12 | $25.27 |
| Average True Range (ATR) | 0.02 | 0.10 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 20.93 | 86.33 |
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.